MicroCHIPS Announces Clinical Results for First Successful Human Trial Of Implantable, Wireless Microchip Drug Delivery Device
- Study Validates Microchip Approach to Multi-Year Drug Delivery Without Injections
- Novel Technology Supports Improved Patient Outcomes and Remote Medicine
WALTHAM, Mass.--(BUSINESS WIRE)--Feb 16, 2012 - MicroCHIPS, Inc., a developer of implantable drug delivery devices and biosensors, announces today the results of the first successful human clinical trial with an implantable, wirelessly controlled and programmable microchip-based drug delivery device. The MicroCHIPS study was published in today's online edition of the journal Science Translational Medicine.
“These data validate the microchip approach to multi-year
drug delivery without the need for frequent injections, which can
improve the management of many chronic diseases like osteoporosis
where adherence to therapy is a significant problem,” said
study lead author
http://www.mchips.com/
MicroCHIPS, Inc. is enabling remote medicine through its
electronic, wirelessly controlled implanted devices. These implants
are designed to improve the health of millions of people with
critical conditions that require careful monitoring and therapy.
The microchip-based implants can sense vital biochemical changes,
deliver potent drug therapies and wirelessly communicate status to
networked patients and clinicians. The technologies use
microreservoir arrays to hermetically store and protect
pharmaceuticals or sensors for extended periods of time. The
microchip is controlled by microprocessors, wireless communications
or sensor feedback loops for precise, dynamic control of drug
delivery or sensing. MicroCHIPS has a deep portfolio of
intellectual property including more than 85 issued or pending
patents with coverage in the US, Europe, the Far East and
throughout the world. MicroCHIPS is funded by leading venture
capital firms Flybridge Capital Partners, InterWest, Intersouth
Partners, Medtronic and Polaris Venture Partners.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50171862&lang=en
Contact: MicroCHIPS
Barbara Yates, 781-258-6153
barbara@theyatesnetwork.com
Posted: February 2012
